Medicine and Science News Releases

View recent medicine and science-related news releases.

 
02/24/2015
Inherited gene variation leaves young leukemia patients at risk for peripheral neuropathy

Research led by St. Jude Children’s Research Hospital investigators could help reduce side effects associated with the anti-cancer drug vincristine, which is widely used to treat cancer in children and adults. (William E. Evans, PharmD)

 
 
02/18/2015
Possible strategy identified to combat major parasitic tropical disease

St. Jude Children’s Research Hospital scientists report results that suggest neutralizing a single protein may aid fight against a parasitic tropical disease that annually sickens more than 1.3 million people worldwide. (Thirumala-Devi Kanneganti, PhD)

 
 
02/13/2015
Survivors of childhood cancer at risk for developing hormone deficiencies as adults

St. Jude Children’s Research Hospital finds childhood cancer patients treated with cranial irradiation may have hormone deficiencies that impact health decades later; results highlight need for lifelong health screenings. (Wassim Chemaitilly, MD)

 
 
02/09/2015
Inherited gene variations tied to treatment-related hearing loss in cancer patients

St. Jude Children’s Research Hospital scientists have identified inherited genetic variations associated with hearing loss in young cancer patients treated with cisplatin, a drug widely used to treat adults with cancer. (Jun J. Yang, PhD, Clinton Stewart, PhD, and Giles Robinson, MD)

 
 
02/04/2015
St. Jude Children’s Research Hospital scientist honored for contributions to immunology

Thirumala-Devi Kanneganti, Ph.D., of St. Jude Children’s Research Hospital, is recognized by the American Association of Immunologists for outstanding research contributions to the field of immunology. (Thirumala-Devi Kanneganti, PhD)

 
 
01/26/2015
Inherited gene variation helps explain drug toxicity in patients of East Asian ancestry

St. Jude researchers have identified an inherited variation in the NUDT15 gene that is strongly associated with a low tolerance for a drug that is a mainstay of pediatric ALL treatment. The finding is expected to impact ALL treatment. (Jun J. Yang, PhD)

 
 
01/15/2015
Tumor suppressor protein plays key role in maintaining immune balance

St. Jude Children’s Research Hospital scientists show that the PTEN tumor suppressor protein is essential for proper regulatory T cell function; discovery offers new focus for improving treatment of autoimmune diseases. (Hongbo Chi, PhD)